Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05379400 · ClinicalTrials.gov registry record · NA

Cleaner Air for Better Cardiac Biomarkers

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT05379400: Completed NA study, sponsored by NYU Langone Health.

NCT05379400 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05379400, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

This pilot project is a randomized, double-blind, sham-controlled trial investigating whether in-home air pollution reductions using portable air cleaners (PACs) can decrease circulating concentrations of biomarkers of inflammation. Using both a targeted approach to study the established biomarker TNFa and an exploratory approach with a commercially available proteomic panel, the researchers will measure concentrations of biomarkers before and after four weeks of home PAC use in a cohort of 74 adults with hypertension recruited from NYU outpatient clinical settings. Participants will also track home blood pressure measurements for additional exploratory analysis of potential mediation of PAC-associated decreases in blood pressure by biomarker concentration changes.

Primary Outcome

Circulating concentrations of TNFα will be measured using the Olink Explore 384 Cardiometabolic panel for this a priori specified analysis.

Interventions

  • OTHER Portable air cleaner (PAC)
  • OTHER Sham Portable air cleaner (PAC)

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2022-08-11
Est. Completion 2023-08-24
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT05379400 record still lists

NCT05379400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Portable air cleaner (PAC) is the first listed.

NCT05379400 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05379400 about?

NCT05379400 is a clinical study titled "Cleaner Air for Better Cardiac Biomarkers". This pilot project is a randomized, double-blind, sham-controlled trial investigating whether in-home air pollution reductions using portable air cleaners (PACs) can decrease circulating concentrations of biomarkers of inflammation. Using both a targeted approach to study the established biomarker T...

What is the current status of trial NCT05379400?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2022-08-11. Estimated completion is 2023-08-24.

What interventions are being tested in trial NCT05379400?

The interventions under investigation include: Portable air cleaner (PAC) (OTHER), Sham Portable air cleaner (PAC) (OTHER).

Who is sponsoring clinical trial NCT05379400?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05379400's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05379400, the US trial registry maintained by the National Library of Medicine. NCT05379400 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.